AI-Rad Companion Brain MR

The AI-Rad Companion Brain MR is a post-processing software designed to automate the segmentation and volumetric quantification of brain structures and white matter hyperintensities from MR images, providing clinicians with quantitative data benchmarked against a healthy population. It employs algorithms operating on T1 MPRAGE and T2 FLAIR sequences, with its white matter hyperintensity analysis validated through non-clinical testing against radiologist-annotated ground truth to ensure performance in image analysis and reporting.

AI-Rad Companion Brain MR is a software tool designed for post-processing analysis of magnetic resonance (MR) brain images. Its primary purpose is to assist clinicians by automating the segmentation and quantitative analysis of various brain structures and white matter hyperintensities (WMH). The software utilizes T1 MPRAGE datasets for volumetric analysis of 30 predefined brain structures, calculating absolute and normalized volumes, and comparing these normalized values against age-matched normative data from a healthy population. Furthermore, it extends its capabilities to analyze WMH using both T1 MPRAGE and T2 weighted FLAIR datasets, providing quantification in terms of count and volume across four brain regions and visualizing these as a 3D overlay map. The system, an enhancement known as VA40, incorporates a white matter hyperintensity analysis algorithm that is technologically similar to that of the reference device, icobrain. Results, including numerical values and visualizations, are presented in an enhanced DICOM Structured Report and archived in PACS for radiological review. The updated version also features a modified deployment structure with cloud and on-premise edge components. Non-clinical performance validation for the new WMH functionality was conducted using data from 89 subjects, including patients with Multiple Sclerosis, Alzheimer's disease, and cognitive impairment, as well as healthy controls. This validation involved comparing the software's automated segmentation results against manual annotations by three radiologists, demonstrating accuracy (e.g., mean Dice score of 0.60 for voxel-wise segmentation) and reproducibility (e.g., mean Dice of 0.79 in reproducibility studies).

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the software's performance in segmenting specific brain structures (beyond global WMH) compare to other established automated methods or manual segmentation, particularly for structures with known inter-rater variability?; What is the variability and accuracy of the normative database used for comparison, especially across diverse demographic groups (e.g., ethnicity, wider age ranges) not fully detailed in the testing cohort?; Can the AI-Rad Companion Brain MR integrate or be trained with local, institution-specific normative data to enhance regional accuracy and applicability?; How does the updated deployment structure (cloud and on-premise edge components) affect data processing times, security, and integration with existing hospital IT infrastructure compared to a cloud-only solution?; What are the specific clinical scenarios or patient populations where the automated WMH quantification offers the most significant diagnostic or prognostic value beyond visual assessment, and how sensitive is it to subtle changes in WMH load over time?